ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 157 filers reported holding ZAI LAB LTD in Q1 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,229,460 | +17.9% | 198,554 | +20.2% | 0.01% | +20.0% |
| Q2 2023 | $2,740,068 | +19.0% | 165,223 | +138.7% | 0.01% | 0.0% |
| Q1 2023 | $2,302,461 | -72.1% | 69,212 | -74.3% | 0.01% | -70.6% |
| Q4 2022 | $8,265,351 | -16.5% | 269,232 | -7.0% | 0.02% | -22.7% |
| Q3 2022 | $9,903,000 | -8.0% | 289,611 | -6.7% | 0.02% | 0.0% |
| Q2 2022 | $10,767,000 | +2552.0% | 310,553 | +3266.8% | 0.02% | +2100.0% |
| Q1 2022 | $406,000 | -30.2% | 9,224 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $582,000 | -90.6% | 9,224 | -84.3% | 0.00% | -90.0% |
| Q3 2021 | $6,175,000 | -18.3% | 58,620 | +37.3% | 0.01% | -23.1% |
| Q2 2021 | $7,555,000 | +640.7% | 42,698 | +457.9% | 0.01% | +550.0% |
| Q1 2021 | $1,020,000 | -60.9% | 7,654 | -60.4% | 0.00% | -60.0% |
| Q4 2020 | $2,610,000 | +758.6% | 19,346 | +428.3% | 0.01% | +400.0% |
| Q3 2020 | $304,000 | +66.1% | 3,662 | +63.8% | 0.00% | – |
| Q2 2020 | $183,000 | – | 2,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |